These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17289213)

  • 1. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis.
    High WA; Ayers RA; Cowper SE
    J Am Acad Dermatol; 2007 Apr; 56(4):710-2. PubMed ID: 17289213
    [No Abstract]   [Full Text] [Related]  

  • 2. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
    Grobner T
    Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors.
    Khurana A; Greene JF; High WA
    J Am Acad Dermatol; 2008 Aug; 59(2):218-24. PubMed ID: 18538448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure].
    Michelet PR; Chopard CS; Martin PY; Vallée JP
    Rev Med Suisse; 2008 Mar; 4(147):576-8, 580. PubMed ID: 18402015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
    Thomsen HS; Morcos SK; Dawson P
    Clin Radiol; 2006 Nov; 61(11):905-6. PubMed ID: 17018301
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephrogenic systemic fibrosis].
    Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
    G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE; Sviland L; Sekse I; Svarstad E
    Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A timely reminder about an evolving clinical entity: nephrogenic systemic fibrosis and gadolinium use in CKD.
    Jamboti J
    Nephrology (Carlton); 2007 Jun; 12(3):316. PubMed ID: 17498132
    [No Abstract]   [Full Text] [Related]  

  • 11. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium and kidney disease: are your patients at risk?
    Hollister D
    Nephrol Nurs J; 2008; 35(2):196-7. PubMed ID: 18472687
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of gadolinium in triggering nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
    Solomon GJ; Rosen PP; Wu E
    Arch Pathol Lab Med; 2007 Oct; 131(10):1515-6. PubMed ID: 17922586
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrogenic systemic fibrosis: experimental studies confound prevailing theory of free gadolinium as a causative factor.
    Jakobsen J
    Acta Radiol; 2008 Jul; 49(6):616-7. PubMed ID: 18568551
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrogenic systemic fibrosis: epidemiology update.
    Marckmann P
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):315-9. PubMed ID: 18408485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of Omniscan in the rat.
    Haylor J; Dencausse A; Vickers M; Nutter F; Jestin G; Slater D; Idee JM; Morcos S
    Invest Radiol; 2010 Sep; 45(9):507-12. PubMed ID: 20697223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrogenic systemic fibrosis or kidney failure--how great is the risk?].
    Rofo; 2010 Feb; 182(2):114-5. PubMed ID: 20120045
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.
    Yerram P; Saab G; Karuparthi PR; Hayden MR; Khanna R
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):258-63. PubMed ID: 17699422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Weiss AS; Lucia MS; Teitelbaum I
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):111-5. PubMed ID: 17251999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital.
    Marckmann P
    Eur J Radiol; 2008 May; 66(2):187-90. PubMed ID: 18328659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.